期刊文献+

高血压合并阵发性房颤采用胺碘酮联合RAS抑制剂治疗的临床体会 被引量:10

Clinical Experience of Amiodarone Combine With RAS Inhibitor Treatment of Hypertension Combine Paroxysmal Atrial Fibrillation
暂未订购
导出
摘要 目的探讨高血压合并阵发性房颤采用胺碘酮联合RAS抑制剂治疗效果。方法选取150患者分为胺碘酮组、坎地沙坦酯组、依那普利组,分析治疗效果。结果 3组患者治疗前舒张压、收缩压和左心房内径对比,P>0.05,差异不具有统计学意义,治疗后舒张压、收缩压和左心房内径对比统,P<0.05,差异具有统计学意义。结论高血压合并阵发性房颤患者经胺碘酮联合RAS抑制剂治疗显著。 Objective To study the treatment effect hypertension with paroxysmal atrial fibrillation with amiodarone combined RAS inhibitor. Methods Selected 150 patients divided into amiodarone group, candesartan ester group and group, analyzed of therapeutic effect. Results The three groups of patients before treatment diastolic and systolic blood pressure and left atrium diameter, P〉0.05, had no difference statistically significance, diastolic blood pressure after treatment, systolic blood pressure and left atrium diameter contrast, P〈0.05, had difference statistically signiifcance. Conclusion Hypertension patients with paroxysmal atrial ifbrillation with amiodarone combined RAS inhibitor treatment.
作者 王秀
出处 《中国继续医学教育》 2015年第19期150-151,共2页 China Continuing Medical Education
关键词 高血压 阵发性房颤 胺碘酮 RAS抑制剂 Hypertension Paroxysmal atrial fibrillation Amiodarone RAS inhibitors
  • 相关文献

参考文献4

二级参考文献17

  • 1戚文航.血管紧张素受体拮抗剂与心房颤动[J].中华心血管病杂志,2004,32(11):1042-1043. 被引量:92
  • 2殷跃辉,刘增长,吴近近,代引,苏立,兰先彬,凌智瑜,杨小渝,罗开良.胺碘酮与氯沙坦、培哚普利联合治疗阵发性心房颤动的前瞻、随机开放研究[J].中华心血管病杂志,2006,34(4):299-302. 被引量:72
  • 3Healey JS,Baranchuk A,Crystal E,et al.Prevention of atrial fibrillation with angiotensin converting enzyme inhibitors and angiotensin receptor blocders:a meta analysis[J].J Am Coll Cardiol,2005,45(11):832-1839.
  • 4Fuster V,Ryden LE,Cannom DS,et al.ACC/AHA/ESC 2006 guidelines for the management of patients with artrial fibrillation[J].Circulation,2006,114(7):700-752.
  • 5AFFIRM First Antiarrhythmic Drug Substudy Investigators.Maintenance of sinus rhythm in patient with atrial fibrillation:an AFFIRM substudy of the first antiarrhythmic drug l[J].J Am Coll Cardio,2003,42(1):20-29.
  • 6Li D,Shinagawa K,Pang L,et al.Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure[J].Circulation,2001,104(21):2608-2614.
  • 7Pedersen OD,Bagger H,Kober L,et al.Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction[J].Circulation,1999,100(4):376-380.
  • 8Madrid AH,Bueno MG,Rebollo JMG,et al.Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation:a prospective and randomized study[J].Circulation,2002,106(3):331-336.
  • 9Okazaki H,Minamino T,Tsukamoto O,et al.Angiotensin Ⅱ type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition[J].Hypertens Res,2006,29(4):277-284.
  • 10Healey JS,Morillo CA,Connolly SJ,et al.Role of the rennin angiotensin aldosterone system in atrial fibrillation and cardiac remodeling[J].Curr Opin Cardiol,2004,20(1):31-37.

共引文献44

同被引文献38

引证文献10

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部